{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:01:55Z","timestamp":1776416515270,"version":"3.51.2"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"DOI":"10.1007\/s11904-026-00784-1","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:24:36Z","timestamp":1776407076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding PrEP Access Through Decentralized Delivery Models"],"prefix":"10.1007","volume":"23","author":[{"given":"Angela","family":"Tembo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarryn","family":"Collings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsitsi","family":"Nyamuzihwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samanta Tresha","family":"Lalla Edward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzette","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WD","family":"Francois Venter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Giovenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"784_CR1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.4102\/sajhivmed.v21i1.1115","volume":"21","author":"J Nel","year":"2020","unstructured":"Nel J, Dlamini S, Meintjes G, Burton R, Black JM, Davies NECG, et al. Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update. South Afr J HIV Med. 2020;21:1115.","journal-title":"South Afr J HIV Med"},{"key":"784_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2022.22246","volume":"329","author":"RT Gandhi","year":"2023","unstructured":"Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the international antiviral society-USA panel: 2022 recommendations of the international antiviral society-USA panel. JAMA. 2023;329:63\u201384.","journal-title":"JAMA"},{"key":"784_CR3","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/hiv.13268","volume":"23","author":"L Ryom","year":"2022","unstructured":"Ryom L, De Miguel R, Cotter AG, Podlekareva D, Beguelin C, Waalewijn H, et al. Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021. HIV Med. 2022;23:849\u201358.","journal-title":"HIV Med"},{"key":"784_CR4","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1016\/S2468-2667(22)00106-2","volume":"7","author":"H Jourdain","year":"2022","unstructured":"Jourdain H, de Gage SB, Desplas D, Dray-Spira R. Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study. Lancet Public Health. 2022;7:e529\u201336.","journal-title":"Lancet Public Health"},{"key":"784_CR5","doi-asserted-by":"publisher","first-page":"e25872","DOI":"10.1002\/jia2.25872","volume":"25","author":"L-G Bekker","year":"2022","unstructured":"Bekker L-G, Pike C, Hillier SL. HIV prevention: better choice for better coverage. J Int AIDS Soc. 2022;25:e25872.","journal-title":"J Int AIDS Soc"},{"key":"784_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11904-011-0078-4","volume":"8","author":"T Kelesidis","year":"2011","unstructured":"Kelesidis T, Landovitz RJ. Preexposure prophylaxis for HIV prevention. Curr HIV\/AIDS Rep. 2011;8:94\u2013103.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"784_CR7","unstructured":"AVAC. The Global PrEP Tracker [Internet]. [cited 2025 May 12]. Available from: https:\/\/data.prepwatch.org\/"},{"key":"784_CR8","unstructured":"UNAIDS. 2024 global AIDS report \u2014 The Urgency of Now: AIDS at a Crossroads [Internet]. [cited 2025 May 12]. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024"},{"key":"784_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/apc.2023.0117","volume":"38","author":"H Nagai","year":"2024","unstructured":"Nagai H, Ankomah A, Fuseini K, Adiibokah E, Semahegn A, Tagoe H. HIV pre-exposure prophylaxis uptake among high-risk population in sub-Saharan Africa: A systematic review and meta-analysis. AIDS Patient Care STDS. 2024;38:70\u201381.","journal-title":"AIDS Patient Care STDS"},{"key":"784_CR10","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","volume":"37","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: A narrative review. Adv Ther. 2020;37:1778\u2013811.","journal-title":"Adv Ther"},{"key":"784_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/COH.0000000000000224","volume":"11","author":"NR Mugo","year":"2016","unstructured":"Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation. Curr Opin HIV AIDS. 2016;11:80\u20136.","journal-title":"Curr Opin HIV AIDS"},{"key":"784_CR12","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.37765\/ajmc.2024.89654","volume":"30","author":"P Sullivan","year":"2024","unstructured":"Sullivan P, Brixner D, Lam JT, Hsiao A. Overcoming barriers to HIV prevention: population health considerations on optimizing PrEP access. Am J Manag Care. 2024;30:S207\u201315.","journal-title":"Am J Manag Care"},{"key":"784_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11904-019-00437-6","volume":"16","author":"G O\u2019Malley","year":"2019","unstructured":"O\u2019Malley G, Barnabee G, Mugwanya K. Scaling-up PrEP delivery in sub-Saharan Africa: What can we learn from the scale-up of ART? Curr HIV\/AIDS Rep. 2019;16:141\u201350.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"784_CR14","unstructured":"WHO. Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance [Internet]. World Health Organization. 2022 [cited 2025 May 12]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240053694"},{"key":"784_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fpubh.2019.00064","volume":"7","author":"RE Glasgow","year":"2019","unstructured":"Glasgow RE, Harden SM, Gaglio B, Rabin B, Smith ML, Porter GC, et al. RE-AIM planning and evaluation framework: Adapting to new science and practice with a 20-year review. Front Public Health. 2019;7:64.","journal-title":"Front Public Health"},{"key":"784_CR16","doi-asserted-by":"publisher","first-page":"e26254","DOI":"10.1002\/jia2.26254","volume":"27","author":"E Rousseau","year":"2024","unstructured":"Rousseau E, Sikkema KJ, Julies RF, Mazer K, O\u2019Malley G, Heffron R, et al. Exploring adolescent girls and young women\u2019s PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa. J Int AIDS Soc. 2024;27:e26254.","journal-title":"J Int AIDS Soc"},{"key":"784_CR17","doi-asserted-by":"publisher","first-page":"e25848","DOI":"10.1002\/jia2.25848","volume":"24","author":"MA Grammatico","year":"2021","unstructured":"Grammatico MA, Moll AP, Choi K, Springer SA, Shenoi SV. Feasibility of a community-based delivery model for HIV pre-exposure prophylaxis among bar patrons in rural South Africa. J Int AIDS Soc. 2021;24:e25848.","journal-title":"J Int AIDS Soc"},{"key":"784_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/s12889-025-21718-3","volume":"25","author":"IV Bassett","year":"2025","unstructured":"Bassett IV, Yan J, Govere S, Shezi S, Ngcobo LM, Sagar S, et al. A pilot cluster randomized controlled trial assessing uptake of PrEP and contraception in hair salons in South Africa. BMC Public Health. 2025;25:524.","journal-title":"BMC Public Health"},{"key":"784_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1186\/s12889-024-18660-1","volume":"24","author":"M Hlongwa","year":"2024","unstructured":"Hlongwa M, Basera W, Nicol E. Comparing PrEP initiation rates by service delivery models among high risk adolescent boys and young men in KwaZulu-Natal, South Africa: findings from a population-based prospective study. BMC Public Health. 2024;24:1151.","journal-title":"BMC Public Health"},{"key":"784_CR20","doi-asserted-by":"publisher","first-page":"e0289353","DOI":"10.1371\/journal.pone.0289353","volume":"18","author":"G Barnabee","year":"2023","unstructured":"Barnabee G, Billah I, Ndeikemona L, Silas L, Ensminger A, MacLachlan E, et al. PrEP uptake and early persistence among adolescent girls and young women receiving services via community and hybrid community-clinic models in Namibia. PLoS ONE. 2023;18:e0289353.","journal-title":"PLoS ONE"},{"key":"784_CR21","doi-asserted-by":"publisher","first-page":"e25968","DOI":"10.1002\/jia2.25968","volume":"25","author":"A Medina-Marino","year":"2022","unstructured":"Medina-Marino A, Bezuidenhout D, Ngwepe P, Bezuidenhout C, Facente SN, Mabandla S, et al. Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa. J Int AIDS Soc. 2022;25:e25968.","journal-title":"J Int AIDS Soc"},{"key":"784_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12889-023-15306-6","volume":"23","author":"PJ Smith","year":"2023","unstructured":"Smith PJ, Daniels J, Bekker LG, Medina-Marino A. What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo city municipality, South Africa. BMC Public Health. 2023;23:418.","journal-title":"BMC Public Health"},{"key":"784_CR23","doi-asserted-by":"publisher","first-page":"232595822311868","DOI":"10.1177\/23259582231186868","volume":"22","author":"KK Giorlando","year":"2023","unstructured":"Giorlando KK, Arnold T, Barnett AP, Leigland A, Whiteley L, Brock JB, et al. Acceptability and Comfort Regarding Remotely Delivered PrEP Services in Mississippi. J Int Assoc Provid AIDS Care. 2023;22:23259582231186868.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"784_CR24","doi-asserted-by":"publisher","first-page":"202201","DOI":"10.1016\/j.jeph.2024.202201","volume":"72","author":"C Faussat","year":"2024","unstructured":"Faussat C, Bonnin A, Hilt D, Rivi\u00e8re-Da Silva F, Baissin C, Michels D, et al. Advantages and limits of remote consultations for HIV pre-exposure prophylaxis health pathway: ePrEP qualitative study. J Epidemiol Popul Health. 2024;72:202201.","journal-title":"J Epidemiol Popul Health"},{"key":"784_CR25","doi-asserted-by":"publisher","first-page":"e25813","DOI":"10.1002\/jia2.25813","volume":"24","author":"P Matambanadzo","year":"2021","unstructured":"Matambanadzo P, Busza J, Mafaune H, Chinyanganya L, Machingura F, Ncube G, et al. It went through the roof: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19. J Int AIDS Soc. 2021;24:e25813.","journal-title":"J Int AIDS Soc"},{"key":"784_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1186\/s12889-021-11335-1","volume":"21","author":"M Jackson-Gibson","year":"2021","unstructured":"Jackson-Gibson M, Ezema AU, Orero W, Were I, Ohiomoba RO, Mbullo PO, et al. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. BMC Public Health. 2021;21:1284.","journal-title":"BMC Public Health"},{"key":"784_CR27","doi-asserted-by":"publisher","first-page":"e25875","DOI":"10.1002\/jia2.25875","volume":"25","author":"E Mudimu","year":"2022","unstructured":"Mudimu E, Sardinia J, Momin S, Medina-Marino A, Bezuidenhout C, Bekker LG, et al. Incremental costs of integrated PrEP provision and effective use counselling in community-based platforms for adolescent girls and young women in South Africa: an observational study. J Int AIDS Soc. 2022;25:e25875.","journal-title":"J Int AIDS Soc"},{"key":"784_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1089\/apc.2024.0159","volume":"38","author":"T Yuh","year":"2024","unstructured":"Yuh T, Lalley-Chareczko L, Zanders D, Shaw H, Spencer T, Serafin D, et al. Acceptability and Feasibility of Implementing a Home-Based HIV Pre-Exposure Prophylaxis Program in an Urban Clinic. AIDS Patient Care STDS. 2024;38:566\u201373.","journal-title":"AIDS Patient Care STDS"},{"key":"784_CR29","doi-asserted-by":"publisher","first-page":"e44468","DOI":"10.2196\/44468","volume":"11","author":"R Shrestha","year":"2023","unstructured":"Shrestha R, Altice FL, Khati A, Azwa I, Gautam K, Gupta S, et al. Clinic-Integrated Smartphone App (JomPrEP) to Improve Uptake of HIV Testing and Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Malaysia: Mixed Methods Evaluation of Usability and Acceptability. JMIR MHealth UHealth. 2023;11:e44468.","journal-title":"JMIR MHealth UHealth"},{"key":"784_CR30","doi-asserted-by":"publisher","first-page":"101037","DOI":"10.1016\/j.bjid.2020.11.002","volume":"25","author":"B Hoagland","year":"2021","unstructured":"Hoagland B, Torres TS, Bezerra DRB, Benedetti M, Pimenta C, Veloso VG, et al. High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil. Braz J Infect Dis. 2021;25:101037.","journal-title":"Braz J Infect Dis"},{"key":"784_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12954-022-00718-1","volume":"19","author":"A Corneli","year":"2022","unstructured":"Corneli A, Perry B, Des Marais A, Choi Y, Chen H, Lilly R, et al. Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine\/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation. Harm Reduct J. 2022;19:132.","journal-title":"Harm Reduct J"},{"key":"784_CR32","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/OLQ.0000000000001872","volume":"50","author":"DM Higgins","year":"2023","unstructured":"Higgins DM, Riba A, Alderton L, Wendel KA, Scanlon J, Weise J, et al. Evaluation of the Impact and Outcomes of a Rapid Transition to Telehealth PrEP Delivery at a Sexual Health Clinic During the COVID-19 Pandemic. Sex Transm Dis. 2023;50:816\u201320.","journal-title":"Sex Transm Dis"},{"key":"784_CR33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10461-021-03195-y","volume":"25","author":"BJ Hill","year":"2021","unstructured":"Hill BJ, Anderson B, Lock L. COVID-19 Pandemic, Pre-exposure Prophylaxis (PrEP) Care, and HIV\/STI Testing Among Patients Receiving Care in Three HIV Epidemic Priority States. AIDS Behav. 2021;25:1361\u20135.","journal-title":"AIDS Behav"},{"key":"784_CR34","doi-asserted-by":"publisher","unstructured":"Cruz-Ba\u00f1ares A, Rojas-Carmona A, Aguilera-Mijares S, Mart\u00ednez-D\u00e1valos A, Bautista-Arredondo S, Vermandere H. Pre-exposure prophylaxis and telemedicine during coronavirus (COVID-19): a qualitative study of the experiences of health care professionals in Mexico. Sex Health [Internet]. 2024;21. Available from: https:\/\/doi.org\/10.1071\/SH23206","DOI":"10.1071\/SH23206"},{"key":"784_CR35","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1080\/09540121.2021.2018567","volume":"34","author":"MS Player","year":"2022","unstructured":"Player MS, Cooper NA, Perkins S, Diaz VA. Evaluation of a telemedicine pilot program for the provision of HIV pre-exposure prophylaxis in the Southeastern United States. AIDS Care. 2022;34:1499\u2013505.","journal-title":"AIDS Care"},{"key":"784_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/apc.2023.0185","volume":"37","author":"EA Andrade","year":"2023","unstructured":"Andrade EA, Betancourt G, Morales G, Zapata O, Marrero L, Rivera S, et al. A Community-Based Pre-Exposure Prophylaxis Telehealth Program Focused on Latinx Sexual Minority Men. AIDS Patient Care STDS. 2023;37:517\u201324.","journal-title":"AIDS Patient Care STDS"},{"key":"784_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1521\/aeap.2024.36.6.428","volume":"36","author":"Y Wu","year":"2024","unstructured":"Wu Y, Chen H, Zhan J, Liu J, Li Y, Cai W, et al. A Differentiated HIV Pre-Exposure Prophylaxis Delivery Model for High-Risk Groups in Nanning City, South China: Findings from a Pilot Program. AIDS Educ Prev. 2024;36:428\u201345.","journal-title":"AIDS Educ Prev"},{"key":"784_CR38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/QAI.0000000000003375","volume":"95","author":"RK Erenrich","year":"2024","unstructured":"Erenrich RK, Braun RA, Torres-Mendoza DM, Stevenson OL, Doan TP, Klausner JD. Effectiveness of PrEPTECH: Findings From a 180-Day Randomized Controlled Trial of a Pre-Exposure Prophylaxis Telehealth Intervention. J Acquir Immune Defic Syndr. 2024;95:463\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"784_CR39","doi-asserted-by":"publisher","first-page":"e26173","DOI":"10.1002\/jia2.26173","volume":"26","author":"A Grangeiro","year":"2023","unstructured":"Grangeiro A, Santos LAD, Estevam DL, Munhoz R, Arruda \u00c9, de Moraes RA, et al. Telehealth effectiveness for pre-exposure prophylaxis delivery in Brazilian public services: the Combine! Study. J Int AIDS Soc. 2023;26:e26173.","journal-title":"J Int AIDS Soc"},{"key":"784_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/apc.2022.0058","volume":"36","author":"JG Rosen","year":"2022","unstructured":"Rosen JG, Zhang L, Pelaez D, Coleman JS, To C, Cooper L, et al. Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study. AIDS Patient Care STDS. 2022;36:313\u201320.","journal-title":"AIDS Patient Care STDS"},{"key":"784_CR41","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1186\/s12889-024-19836-5","volume":"24","author":"DI Alohan","year":"2024","unstructured":"Alohan DI, Evans G, Sanchez T, Harrington KRV, Quamina A, Young HN, et al. Using the andersen healthcare utilization model to assess willingness to screen for prep in pharmacy-based settings among cisgender sexually minoritized men: results from the 2020 american men\u2019s internet survey. BMC Public Health. 2024;24:2349.","journal-title":"BMC Public Health"},{"key":"784_CR42","doi-asserted-by":"crossref","unstructured":"Herron G, Leong A, Patel K, Rasekhi K, Apollonio DE. Assessment of PrEP and PEP furnishing in San Francisco Bay Area pharmacies: An observational cross-sectional study. J Am Pharm Assoc (2003). 2024;64:102201.","DOI":"10.1016\/j.japh.2024.102201"},{"key":"784_CR43","doi-asserted-by":"publisher","first-page":"e26131","DOI":"10.1002\/jia2.26131","volume":"26","author":"KF Ortblad","year":"2023","unstructured":"Ortblad KF, Mogere P, Omollo V, Kuo AP, Asewe M, Gakuo S, et al. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation. J Int AIDS Soc. 2023;26:e26131.","journal-title":"J Int AIDS Soc"},{"key":"784_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/QAI.0000000000003208","volume":"93","author":"V Omollo","year":"2023","unstructured":"Omollo V, Asewe M, Mogere P, Maina G, Kuo AP, Odoyo J, et al. The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya. J Acquir Immune Defic Syndr. 2023;93:379\u201386.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"784_CR45","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1186\/s12889-023-16072-1","volume":"23","author":"CM Khosropour","year":"2023","unstructured":"Khosropour CM, Riley T, Healy E, Backus KV, Gomillia CE, Mena L, et al. Persistence in a pharmacist-led, same-day PrEP program in Mississippi: a mixed-methods study. BMC Public Health. 2023;23:1130.","journal-title":"BMC Public Health"},{"key":"784_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10461-024-04519-4","volume":"29","author":"CE Martin","year":"2025","unstructured":"Martin CE, Blaauw D, Nongena P, Chidumwa G, Dada S, Jack S, et al. Preferences for delivery of HIV prevention services among healthcare users in South Africa: A discrete choice experiment. AIDS Behav. 2025;29:331\u201341.","journal-title":"AIDS Behav"},{"key":"784_CR47","doi-asserted-by":"publisher","first-page":"e25242","DOI":"10.1002\/jia2.25242","volume":"22","author":"J Han","year":"2019","unstructured":"Han J, Bouey JZ, Wang L, Mi G, Chen Z, He Y, et al. PrEP uptake preferences among men who have sex with men in China: results from a National Internet Survey. J Int AIDS Soc. 2019;22:e25242.","journal-title":"J Int AIDS Soc"},{"key":"784_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.46234\/ccdcw2025.012","volume":"7","author":"S Wang","year":"2025","unstructured":"Wang S, Kang W, Hu J, Zhang D, Xu J, Tang H, et al. Synergizing Digital and physical approaches: Experience summary of the HIV PrEP promotion project. China CDC Wkly. 2025;7:61\u20136.","journal-title":"China CDC Wkly"},{"key":"784_CR49","doi-asserted-by":"publisher","first-page":"e014709","DOI":"10.1136\/bmjgh-2023-014709","volume":"9","author":"CJ Heck","year":"2024","unstructured":"Heck CJ, Dam A, Yohannes K, Deacon J, Kripke K, Meyers K, et al. Lessons learnt from daily oral PrEP delivery to inform national planning for PrEP ring introduction for women in low-income and middle-income countries: a qualitative inquiry of international stakeholders. BMJ Glob Health. 2024;9:e014709.","journal-title":"BMJ Glob Health"},{"key":"784_CR50","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.4102\/hsag.v29i0.2412","volume":"29","author":"SH Mboweni","year":"2024","unstructured":"Mboweni SH. Strategies that enabled access to chronic care during the COVID-19 pandemic and beyond in South Africa. Health SA Gesondheid. 2024;29:2412.","journal-title":"Health SA Gesondheid"},{"key":"784_CR51","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/13625187.2020.1810226","volume":"25","author":"J Ramos-Ortiz","year":"2020","unstructured":"Ramos-Ortiz J, Strube OL, Kinman N, Meier S, DeMaria AL. Condom-vending machines in Italy: a qualitative exploration of gender differences to improve promotion and use. Eur J Contracept Reprod Health Care. 2020;25:456\u201364.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"784_CR52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/sextrans-2023-055969","volume":"100","author":"M Gobin","year":"2024","unstructured":"Gobin M, Dhillon S, Kesten JM, Horwood J, Dean GL, Stockwell S, et al. Acceptability of digital vending machines to access STI and HIV tests in two UK cities. Sex Transm Infect. 2024;100:91\u20137.","journal-title":"Sex Transm Infect"},{"key":"784_CR53","doi-asserted-by":"publisher","first-page":"e25897","DOI":"10.1002\/jia2.25897","volume":"25","author":"Y-F Huang","year":"2022","unstructured":"Huang Y-F, Huang Y-C, Lo Y-C, Latkin C, Huang H-Y, Lee C-C, et al. Towards the first 90: impact of the national HIV self-test program on case finding and factors associated with linkage to confirmatory diagnosis in Taiwan. J Int AIDS Soc. 2022;25:e25897.","journal-title":"J Int AIDS Soc"},{"key":"784_CR54","doi-asserted-by":"publisher","first-page":"NULL","DOI":"10.1071\/SH23118","volume":"21","author":"D Evans","year":"2024","unstructured":"Evans D, Cowen K, Fairley C, Randall C, Hocking J, Ludwick T, et al. STI-X: a novel approach to STI testing in rural and regional Victoria, Australia. Sex Health. 2024;21:NULL.","journal-title":"Sex Health"},{"key":"784_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12954-023-00829-3","volume":"20","author":"JG Walker","year":"2023","unstructured":"Walker JG, Kirtadze I, Tabatadze M, Vickerman P, Otiashvili D. Costs of syringe vending machines in Tbilisi, Georgia. Harm Reduct J. 2023;20:103.","journal-title":"Harm Reduct J"},{"key":"784_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-023-00765-2","volume":"20","author":"E Russell","year":"2023","unstructured":"Russell E, Johnson J, Kosinski Z, Kaplan C, Barnes N, Allen S, et al. A scoping review of implementation considerations for harm reduction vending machines. Harm Reduct J. 2023;20:33.","journal-title":"Harm Reduct J"},{"key":"784_CR57","doi-asserted-by":"publisher","first-page":"S558","DOI":"10.2105\/AJPH.2024.307718","volume":"114","author":"D Jamerson","year":"2024","unstructured":"Jamerson D, Franich K, Lockett C. Equitable COVID-19 testing access for underserved communities: The success of vending machines. Am J Public Health. 2024;114:S558\u201361.","journal-title":"Am J Public Health"},{"key":"784_CR58","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1177\/15248399221098016","volume":"24","author":"AL DeMaria","year":"2023","unstructured":"DeMaria AL, Hughes-Wegner AT, Rogozinski F, Raff T, Szabo MM, Noel N. Developing, implementing, and evaluating a campus-wide Pharmacy vending machine program. Health Promot Pract. 2023;24:950\u20135.","journal-title":"Health Promot Pract"},{"key":"784_CR59","first-page":"123","volume":"9","author":"P Oleszkiewicz","year":"2021","unstructured":"Oleszkiewicz P, Krysinski J, Religioni U, Merks P. Access to medicines via non-pharmacy outlets in European countries-A review of regulations and the influence on the self-medication phenomenon. Healthc (Basel). 2021;9:123.","journal-title":"Healthc (Basel)"},{"key":"784_CR60","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1080\/07853890.2022.2121418","volume":"54","author":"ST Allen","year":"2022","unstructured":"Allen ST, O\u2019Rourke A, Johnson JA, Cheatom C, Zhang Y, Delise B, et al. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada. Ann Med. 2022;54:2692\u2013700.","journal-title":"Ann Med"},{"key":"784_CR61","doi-asserted-by":"publisher","first-page":"209584","DOI":"10.1016\/j.josat.2024.209584","volume":"169","author":"R Martin","year":"2025","unstructured":"Martin R, DaCunha A, Bailey A, Joseph R, Kane K. Evaluating public health vending machine rollout and utilization in criminal-legal settings. J Subst Use Addict Treat. 2025;169:209584.","journal-title":"J Subst Use Addict Treat"},{"key":"784_CR62","doi-asserted-by":"publisher","first-page":"209521","DOI":"10.1016\/j.josat.2024.209521","volume":"167","author":"G Victor","year":"2024","unstructured":"Victor G, Hedden-Clayton B, Lenz D, Attaway PR, Ray B. Naloxone vending machines in county jail. J Subst Use Addict Treat. 2024;167:209521.","journal-title":"J Subst Use Addict Treat"},{"key":"784_CR63","doi-asserted-by":"crossref","unstructured":"Arendt D. Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine. J Am Pharm Assoc (2003). 2023;63:309\u201316.","DOI":"10.1016\/j.japh.2022.10.027"},{"key":"784_CR64","doi-asserted-by":"crossref","unstructured":"Herrera A. Advancing equitable access to harm reduction: Implementation and early use of an outdoor harm reduction vending machine, Kern County, California, 2023. Public Health Rep. 2025;333549241308169.","DOI":"10.1177\/00333549241308169"},{"key":"784_CR65","doi-asserted-by":"publisher","unstructured":"Dahlem CHG, English E, Dwan M, Carlson C, Dora-Laskey A, Kocher KE et al. Implementation of a naloxone vending machine in the public space of an emergency department: A feasibility and acceptability study. J Emerg Nurs [Internet]. 2025 [cited 2025 May 12]; Available from: https:\/\/doi.org\/10.1016\/j.jen.2025.03.009","DOI":"10.1016\/j.jen.2025.03.009"},{"key":"784_CR66","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/jphsr\/rmac044","volume":"13","author":"AA Jairoun","year":"2022","unstructured":"Jairoun AA, Al-Hemyari SS, Shahwan M, El-Dahiyat F, Jairoun M, Godman B, et al. Access to non-prescription medicines via vending machines: key considerations to help transfer the self-care concept to the next generation while managing safety risks. J Pharm Health Serv Res. 2022;13:396\u2013401.","journal-title":"J Pharm Health Serv Res"},{"key":"784_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-019-0292-8","volume":"16","author":"D Otiashvili","year":"2019","unstructured":"Otiashvili D, Kirtadze I, Vardanashvili I, Tabatadze M, Ober AJ. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia. Harm Reduct J. 2019;16:1\u201312.","journal-title":"Harm Reduct J"},{"key":"784_CR68","unstructured":"Lebelo K. An implementation science project to evaluate uptake, coverage and effectiveness of a youth-focussed, decentralized district-wide PrEP program. World Congress of Epidemiology; 2024. Available from: https:\/\/www.wce2024.org\/wp-content\/uploads\/2024\/10\/Keitumetse-SYM14-Bridging-the-gap-the-epidemiology-and-strategic-implementation-of-pre-exposure-prophylaxis-PrEP-in-HIV-prevention.pdf"},{"key":"784_CR69","unstructured":"Pienaar J, Rawlinson R, Ncube V, Chabane M. Elevating PrEP access: a game-changing ePharmacy model for key populations in South Africa [Internet]. AIDS. 2024 conference abstract; 2024. Available from: https:\/\/www.iasociety.org\/sites\/default\/files\/AIDS2024\/abstract-book\/AIDS-2024_Abstracts.pdf"},{"key":"784_CR70","unstructured":"Tembo A, Nyamuzihwa T, Lalla-Edward S, Edem E, Martyn N, Mkansi M, Tinzi S, Wonderlink T, Makola L, Kelechi E, Nyatela A, Venter WDF. Community pharmacy initiated and management of oral pre-exposure prophylaxis (PrEP) among men and women at substantial risk HIV acquisition in South Africa: interim results [Internet]. AIDS 2024 conference abstract; 2024. Available from: https:\/\/www.iasociety.org\/sites\/default\/files\/AIDS2024\/abstract-book\/AIDS-2024_Abstracts.pdf"},{"key":"784_CR71","unstructured":"Nyamuzihwa T, Tembo A, Edem E, Mkansi M, Mkhize A, Phahla C, Wonderlik T, Martyn N, Makola L, Guramatunhu T, Motsoari M, Venter F. Interim results from an online pre-exposure prophylaxis (PrEP) pilot for men and women in Gauteng province, South Africa [Internet]. AIDS 2024 conference abstract; 2024. Available from: https:\/\/www.iasociety.org\/sites\/default\/files\/AIDS2024\/abstract-book\/AIDS-2024_Abstracts.pdf"},{"key":"784_CR72","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12913-022-07742-8","volume":"22","author":"SD Roche","year":"2022","unstructured":"Roche SD, Barnabee G, Omollo V, Mogaka F, Odoyo J, Bukusi EA, et al. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study. BMC Health Serv Res. 2022;22:422.","journal-title":"BMC Health Serv Res"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00784-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-026-00784-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00784-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:04:17Z","timestamp":1776413057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-026-00784-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1007\/s11904-026-00784-1","relation":{},"ISSN":["1548-3576"],"issn-type":[{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WDF Venter reports institutional funding from the Bill & Melinda Gates Foundation, SA Medical Research Council, NIH, Unitaid, and others; investigator-initiated and commercial study support from multiple pharmaceutical companies; and personal honoraria from Gilead, ViiV, Merck, and others. He also serves on various PrEP guideline committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"16"}}